BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3094341)

  • 21. Effects of arachidonic acid concentration on prostaglandin biosynthesis and feasibility of semibatch processes.
    Sada E; Katoh S; Kheirolomoom A
    Appl Biochem Biotechnol; 1989 Dec; 22(3):247-61. PubMed ID: 2512852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromoacetamido-analogs of indomethacin and mefenamic acid affinity-label prostaglandin H2 synthase at two sites.
    Tang MS; Askonas LJ; Penning TM
    Adv Exp Med Biol; 1997; 400A():77-84. PubMed ID: 9547540
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostaglandin H synthase and hydroperoxides: peroxidase reaction and inactivation kinetics.
    Kulmacz RJ
    Arch Biochem Biophys; 1986 Sep; 249(2):273-85. PubMed ID: 3092738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase.
    Ku EC; Wasvary JM; Cash WD
    Biochem Pharmacol; 1975 Mar; 24(5):641-3. PubMed ID: 804905
    [No Abstract]   [Full Text] [Related]  

  • 25. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.
    Kulmacz RJ; Lands WE
    J Biol Chem; 1985 Oct; 260(23):12572-8. PubMed ID: 3930499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of prostaglandin synthase by pirprofen. Studies with sheep seminal vesicle enzyme.
    Ku EC; Wasvary JM
    Biochim Biophys Acta; 1975 Apr; 384(2):360-8. PubMed ID: 804924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of saturated fatty acids on prostaglandin synthetase activity.
    Robak J; Dembińska-Kieć A; Gryglewski R
    Biochem Pharmacol; 1975 Nov; 24(22):2057-60. PubMed ID: 813641
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro inhibition and stimulation of purified prostaglandin endoperoxide synthase by flavonoids: structure-activity relationship.
    Kalkbrenner F; Wurm G; von Bruchhausen F
    Pharmacology; 1992; 44(1):1-12. PubMed ID: 1553387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin synthetase catalyzed activation of paracetamol.
    Moldéus P; Andersson B; Rahimtula A; Berggren M
    Biochem Pharmacol; 1982 Apr; 31(7):1363-8. PubMed ID: 6807320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ascorbic acid and prostaglandin formation.
    Beetens JR; Herman AG
    Int J Vitam Nutr Res Suppl; 1983; 24():131-44. PubMed ID: 6414965
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoxygenation activity of purified prostaglandin-forming cyclooxygenase.
    Hemler ME; Crawford CG; Lands WE
    Biochemistry; 1978 May; 17(9):1772-9. PubMed ID: 26389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates.
    Thompson D; Eling T
    Mol Pharmacol; 1989 Nov; 36(5):809-17. PubMed ID: 2511429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin synthetase dependent benzo(a)pyrene oxidation: products of the oxication and inhibition of their formation by antioxidants.
    Marnett LJ; Reed GA; Johnson JT
    Biochem Biophys Res Commun; 1977 Nov; 79(2):569-76. PubMed ID: 412501
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-viniferin: a prostaglandin H2 synthase inhibitor from root of Carex humilis.
    Lee SH; Shin NH; Kang SH; Park JS; Chung SR; Min KR; Kim Y
    Planta Med; 1998 Apr; 64(3):204-7. PubMed ID: 9581514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of 3-methylindole by prostaglandin H synthase in ram seminal vesicles.
    Formosa PJ; Bray TM; Kubow S
    Can J Physiol Pharmacol; 1988 Dec; 66(12):1524-30. PubMed ID: 2852537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of cannabis constituents on enzymes of arachidonate metabolism: anti-inflammatory potential.
    Evans AT; Formukong EA; Evans FJ
    Biochem Pharmacol; 1987 Jun; 36(12):2035-7. PubMed ID: 3109435
    [No Abstract]   [Full Text] [Related]  

  • 37. Target size analysis of prostaglandin endoperoxide synthase. Radiation inactivation of both cyclooxygenase and peroxidase correlated with the monomer of 72 kDa.
    Ruf HH; Schuhn D; Dietz R; Nastainczyk W; Nielsen M
    Eur J Biochem; 1992 Mar; 204(3):1069-73. PubMed ID: 1312929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orientation of the active site and antigenic determinants of prostaglandin endoperoxide synthase in the endoplasmic reticulum.
    DeWitt DL; Rollins TE; Day JS; Gauger JA; Smith WL
    J Biol Chem; 1981 Oct; 256(20):10375-82. PubMed ID: 6169719
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of some flavonoids on non-enzymatic lipid oxidation and enzymatic oxidation of arachidonic acid.
    Robak J; Duniec Z; Rzadkowska-Bodalska H; Olechnowicz-Stepień W; Cisowski W
    Pol J Pharmacol Pharm; 1986; 38(5-6):483-91. PubMed ID: 3106941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic properties of prostaglandin synthetase from bovine seminal vesicles.
    Duvivier J; Wolf D; Heusghem C
    Biochimie; 1975; 57(5):521-8. PubMed ID: 810179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.